Financial & Business News

LATEST INVESTING HEADLINES

SQSP Stock News Image - accesswire.com

NEW YORK, NY / ACCESSWIRE / May 30, 2024 / Leading law firm Bleichmar Fonti & Auld LLP is investigating the Squarespace (NYSE:SQSP) buyout from Permira. If you invested in Squarespace you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases/squarespace-inc-investigation.

accesswire.com 2024 May 30
SPT Stock News Image - accesswire.com

NEW YORK, NY / ACCESSWIRE / May 30, 2024 / Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 12, 2024, deadline in the Sprout Social (Nasdaq:SPT) Securities Class Action Lawsuit. If you invested in Sprout Social, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases/sprout-social-inc-investigation.

accesswire.com 2024 May 30
JYNT Stock News Image - globenewswire.com

SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) -- Royale Energy, Inc. (OTCQB: ROYL) is pleased to announce new progress on its Joint Development Agreement (JDA) with Ares Energy LTD, located in the Permian Basin, Texas. This project is a horizontal resource play in the Mississippian interval.

globenewswire.com 2024 May 30
CERE Stock News Image - accesswire.com

NEW YORK, NY / ACCESSWIRE / May 30, 2024 / Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between Cerevel Therapeutics Holdings, Inc. (Nasdaq:CERE) and AbbVie, Inc. If you invested in Cerevel Therapeutics you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases/cerevel-therapeutics-holdings-inc-investigation . Claim Details: On December 6, 2023, Cerevel Therapeutics announced that it would be acquired by AbbVie.

accesswire.com 2024 May 30
CAE Stock News Image - accesswire.com

NEW YORK, NY / ACCESSWIRE / May 30, 2024 / Top securities law firm Bleichmar Fonti & Auld LLP announces an investigation into CAE, Inc. (NYSE:CAE) for potential violations of the federal securities laws. If you invested in CAE, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases/cae-inc-investigation.

accesswire.com 2024 May 30
EXPR Stock News Image - seekingalpha.com

American Express Company stock has seen significant price advancement, outpacing the S&P 500 Index. Key drivers include strong demand from Millennial and Gen Z customers, which should continue, in our view. However, we are concerned over the provision for credit losses and the subsequent risks in the face of macroeconomic uncertainties, which could cause even higher delinquency rates.

seekingalpha.com 2024 May 30
WOW Stock News Image - accesswire.com

NEW YORK, NY / ACCESSWIRE / May 30, 2024 / Leading law firm Bleichmar Fonti & Auld LLP is investigating the WideOpenWest (NYSE:WOW) merger with DigitalBridge and Crestview. If you invested in WideOpenWest you are encouraged to contact BFA Law by visiting https://www.bfalaw.com/cases/wideopenwest-inc-investigation.

accesswire.com 2024 May 30
BIIB Stock News Image - accesswire.com

NEW YORK, NY / ACCESSWIRE / May 30, 2024 / Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (Nasdaq:BIIB) Securities Class Action Lawsuit. If you invested in Biogen, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases/biogen-inc-investigation.

accesswire.com 2024 May 30
CRM Stock News Image - investopedia.com

Salesforce (CRM) shares extended their earnings-fueled decline in intraday trading Thursday after the customer relationship management (CRM) company reported first-quarter sales that missed estimates and offered weaker-than-expected guidance for the second quarter. Analysts lowered their price targets for Salesforce stock following the lackluster earnings report, though several maintained "buy" ratings, noting Salesforce could benefit from enterprise customers integrating artificial intelligence (AI).

investopedia.com 2024 May 30
AGEN Stock News Image - investorplace.com

Human life expectancy has doubled since the 1900s, mostly attributed to advancements in lifestyle, living standards and medicine. Thanks to biotech companies that produce transformative drugs and treatments, we now have the collective ability to combat diseases that used to bring entire nations down.

investorplace.com 2024 May 30
10 of 1,000